WuXi Pharmatech Named A Red Herring 100 Asia Company
Sep 07, 2005
September 7, 2005 - Shanghai, China - WuXi PharmaTech today announced that it has been named one of the Red Herring 100 Private Companies of Asia. "Getting selected for the Red Herring Asia 100 list is quite an achievement," said Red Herring editor-in-chief Joel Dreyfuss. "We had many strong entries, a reflection of depth of entrepreneurship that has taken hold in Asia." In addition, WuXi PharmaTech is the only Mainland pharmaceutical R&D company selected for this honor.
"We are very pleased to be selected by Red Herring as one of the top 100 private companies in Asia." commented Dr. Ge Li, founder and CEO of WuXi PharmaTech, during the conference, "The award is not only a recognition of our achievement and unique business model, but also an encouragement for us to build WuXi PharmaTech into a world-class company."
During the past few months, Red Herring's editorial staff rigorously evaluated more than 500 private companies through a careful analysis of financial data and subjective criteria, including quality of management, execution of strategy, and dedication to research and development. The decision to award WuXi PharmaTech a "100 Asia Company" reflects that the company's leading position in the pharmaceutical R&D service industry has been recognized throughout Asia and beyond. WuXi PharmaTech as well as other award winners presented their business models, strategies and visions at the Red Herring 100 Asia Conference that took place on September 5-7 at the Shangri-La Hotel in Shanghai, China.
About Red Herring 100 Asia Conference
Red Herring 100 Asia Conference is an invitation-only event for CEOs, select senior executives, and Venture Capitalists. Red Herring 100 Asia will bring together executives from mostly private companies. These executives will be joined by senior executives from public companies and Venture Capitalists.
About Red Herring
Red Herring is the weekly magazine technology entrepreneurs, investors and industry observers read to stay ahead of the curve and to be better informed about the global marketplace. Red Herring covers technology, innovation, financial strategies, important personalities and trends that are transforming the world of business with unique insight, opinion and forward-looking analysis. Readers turn to Red Herring for knowledge to make strategic decisions, build companies and create a competitive advantage for their businesses. Red Herring articles, blogs, research and event information can be found online at www.redherring.com.
The list of Red Herring 100 Private Companies in Asia can be found online
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.